The rate of alcohol metabolism varies from person to person
The advent of incretin-based therapies and the expansion to multi-receptor agonist peptides targeting glucagon-like peptide 1 (GLP1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin receptors has transformed obesity treatment, demonstrating average weight loss of more than 20% in humans and improvements in a broad range of obesity-related comorbidities
Exact LIP-C formulations vary by compounding pharmacy and prescriber order
It is important to understand that while these ingredients provide powerful biochemical support, they are not a standalone cure
At Milestone Treatment Center, our board-certified addiction physicians evaluate each client individually to determine if off-label GLP-1 protocol is a safe, appropriate option
(Box 1) [33-37] The association between GH-IGF and carcinogenesis is also suggested by the observation that patients suffering from acromegaly, an endocrine disorder characterized by sustained hypersecretion of GH and consequent increased levels of IGF-I, have a higher risk of developing colorectal and thyroid cancer [38-42]
